potassium bicarbonate + potassium chloride: clinical use

Prescribing considerations

• Identify and address the underlying cause of low blood potassium.
• Oral replacement may be unsuitable when correction is immediately required, gastrointestinal absorption is limited, or oral treatment cannot be tolerated.
• Consider concurrent potassium-retaining medicines and dietary or supplementary potassium.
• The product contains sucrose and is unsuitable in specified rare hereditary disorders of sugar metabolism.

Contraindications and cautions

• High blood potassium from any cause.
• Severe renal impairment with oliguria.
• Inadequately treated Addison's disease.
• Acute dehydration or crush injury.
• Hypersensitivity to an active substance or excipient.
• Rare hereditary fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency.

Monitoring

• Clinical response and serum electrolytes.
• Renal function and risk of potassium accumulation.
• ECG, particularly with cardiac disease or digitalis treatment.
• Acid–base balance in acidosis.
• Consider magnesium assessment where deficiency may coexist.

Clinical pharmacology

The potassium salts dissociate to provide absorbable potassium. Potassium is predominantly intracellular and supports membrane transport, neuromuscular activity and cardiac electrophysiology; elimination is mainly renal.

Formulation and product differences

• The selected product combines potassium chloride and potassium bicarbonate in an effervescent tablet dissolved before administration.
• The chloride component supports replacement in hypochloraemic alkalosis.
• Dissolution limits high local gastrointestinal concentrations compared with swallowing a solid potassium salt preparation.
• It contains sucrose and must be stored tightly closed and protected from moisture.
• Oral potassium formulations differ in salt, concentration and release characteristics and should not be interchanged by tablet count alone.